KCT0005212招募中未知
Validation for clinical utility of biomarkers for the early diagnosis of breast cancer
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 496
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 18(Year) 至 80(Year)（—）
- 性别
- Female
入选标准
- •Breast Cancer patients
- •- Women over 18
- •- Patients diagnosed with breast cancer by biopsy before treatment (patients before surgery and neoadjuvant chemotherapy)
排除标准
- •- Carcinoma in situ
- •- Recurrent breast cancer patient
- •- Any person diagnosed with another cancer within five years.
- •- Patients who started treatment after being diagnosed with breast cancer
研究者
相似试验
尚未招募
不适用
Phyisician Led CIMAvax-EGF lung biomarkersAdvanced non small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesRPCEC00000355Center of Molecular Immunology (CIM)140
已完成
4 期
Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 days) Antibiotic Treatment with Conventional Treatment (14 days)febrile urinary tract infection or pyelonephritis1000401810046590NL-OMON39150eids Universitair Medisch Centrum500
进行中（未招募）
不适用
Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 days) Antibiotic Treatment with Conventional Treatment (14 days) - FUTIRST (Febrile Urinary Tract Infection Randomized Short Treatment)EUCTR2008-001081-80-NLeiden University Medical Center500
招募中
不适用
Febrile Urinary Tract Infection Randomized Short Treatment Trial.urinary tarct infection, acute pyelonephritis, urosepsisNL-OMON20802eiden University Medical Center400
招募中
不适用
Pilot study: clinical evaluation of biomarkers as predictors of survival in castrate-resistant prostate cancer patients.NL-OMON34838niversitair Medisch Centrum Sint Radboud50